Information is provided on efavirenz (Sustiva, formerly DMP-266), including dosage information, resistance and clinical trial results, and pharmacology. Side effects are reviewed, as are interactions with other anti-HIV drugs. Contact information is provided.
|Original language||English (US)|
|Number of pages||1|
|Journal||The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service|
|State||Published - 1999|